Oxford vaccine trial pause won't have impact on Indian trials: Serum Institute CEO
  • 4 years ago
After clinical trials of the Covid-19 vaccine developed by the Oxford University and AstraZeneca have been halted after a participant had an adverse reaction in the UK-- Serum Institute of India has issued a statement to clear the air on the impending trials of the vaccine in India.
Recommended